0001209191-20-024640.txt : 20200416 0001209191-20-024640.hdr.sgml : 20200416 20200416160916 ACCESSION NUMBER: 0001209191-20-024640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200414 FILED AS OF DATE: 20200416 DATE AS OF CHANGE: 20200416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Winter Gregory Paul CENTRAL INDEX KEY: 0001777021 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 20796494 MAIL ADDRESS: STREET 1: /O BICYCLE THERAPEUTICS LIMITED STREET 2: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB222 3AT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-14 0 0001761612 BICYCLE THERAPEUTICS plc BCYC 0001777021 Winter Gregory Paul C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 1 0 0 0 Ordinary Shares 2020-04-14 4 M 0 71450 A 163927 D Series A Preferred Shares Warrant 2020-04-14 4 M 0 71450 0.00 D Ordinary Shares 71450 71450 D The Warrants to purchase Series A Preferred Shares had an exercise price of a nominal value per Series A Preferred Share, and, following Bicycle Therapeutics plc's initial public offering, became exercisable for ordinary shares. The Warrants are immediately exercisable and expire on May 26, 2027. /s/ Lee Kalowski, Attorney-in-Fact 2020-04-16